Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of $173.70 million as of June 20, 2025. Its market cap has decreased by -19.63% in one year.

Market Cap

173.70M

Enterprise Value

220.37M

Revenue

53.20M

Ranking

n/a

PE Ratio

10.59

Stock Price

$12.00

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 257.00M to 173.70M, a decrease of -32.41%. That is a compound annual growth rate of -2.09%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	173.70M	-9.54%
Dec 30, 2024	192.01M	83.04%
Dec 29, 2023	104.90M	250.69%
Dec 30, 2022	29.91M	-5.41%
Dec 30, 2021	31.62M	-27.17%
Dec 30, 2020	43.42M	-62.90%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.62B
Veradigm	755.74M
Elite Pharmaceuticals	715.74M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	637.25M
American Oncology Network	414.48M
Glass House Brands	408.56M
CytoDyn	398.27M

Market Cap Rankings